A Bioavailability Study with Alternate Methods of Administration of Naloxegol Tablets, and Solution

Trial Identifier: D3820C00035
Sponsor: AstraZeneca
NCTID:: NCT02446171
Start Date: May 2015
Primary Completion Date: July 2015
Study Completion Date: July 2015
Condition: Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Germany Berlin, Germany